Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2

被引:7
|
作者
Ahn, Terrie S. [1 ]
Han, Brandon [2 ,3 ]
Krogstad, Paul [2 ,4 ]
Bun, Chantana [1 ]
Kohn, Lisa A. [1 ]
Garcia-Lloret, Maria I. [1 ]
Damoiseaux, Robert [2 ,3 ,5 ]
Butte, Manish J. [1 ,6 ]
机构
[1] Univ Calif Los Angeles, Dept Pediat, Div Immunol Allergy & Rheumatol, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA
[5] Univ Calif Los Angeles, Dept Bioengn, Samueli Sch Engn, Los Angeles, CA USA
[6] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
关键词
INTRAVENOUS IMMUNOGLOBULIN;
D O I
10.1016/j.jaci.2020.12.003
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:876 / 877
页数:2
相关论文
共 50 条
  • [1] Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
    Tai, Wanbo
    Zhang, Xiujuan
    He, Yuxian
    Jiang, Shibo
    Du, Lanying
    ANTIVIRAL RESEARCH, 2020, 179
  • [2] Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses
    Bullen, Georgia
    Galson, Jacob D.
    Hall, Gareth
    Villar, Pedro
    Moreels, Lien
    Ledsgaard, Line
    Mattiuzzo, Giada
    Bentley, Emma M.
    Masters, Edward W.
    Tang, David
    Millett, Sophie
    Tongue, Danielle
    Brown, Richard
    Diamantopoulos, Ioannis
    Parthiban, Kothai
    Tebbutt, Claire
    Leah, Rachael
    Chaitanya, Krishna
    Ergueta-Carballo, Sandra
    Pazeraitis, Deividas
    Surade, Sachin B.
    Ashiru, Omodele
    Crippa, Lucia
    Cowan, Richard
    Bowler, Matthew W.
    Campbell, Jamie I.
    Lee, Wing-Yiu Jason
    Carr, Mark D.
    Matthews, David
    Pfeffer, Paul
    Hufton, Simon E.
    Sawmynaden, Kovilen
    Osbourn, Jane
    McCafferty, John
    Karatt-Vellatt, Aneesh
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
    Grobben, Marloes
    van der Straten, Karlijn
    Brouwer, Philip J. M.
    Brinkkemper, Mitch
    Maisonnasse, Pauline
    Dereuddre-Bosquet, Nathalie
    Appelman, Brent
    Lovell, A. H. Ayesha
    van Vught, Lonneke A.
    Burger, Judith A.
    Poniman, Meliawati
    Oomen, Melissa
    Eggink, Dirk
    Bijl, Tom P. L.
    van Willigen, Hugo D. G.
    Wynberg, Elke
    Verkaik, Bas J.
    Figaroa, Orlane J. A.
    de Vries, Peter J.
    Boertien, Tessel M.
    Bomers, Marije K.
    Sikkens, Jonne J.
    Le Grand, Roger
    de Jong, Menno D.
    Prins, Maria
    Chung, Amy W.
    de Bree, Godelieve J.
    Sanders, Rogier W.
    van Gils, Marit J.
    ELIFE, 2021, 10
  • [4] Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: Implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies
    Li, Shibo
    Wu, Jianbo
    Jiang, Weiyu
    He, Haiyan
    Zhou, Yunjiao
    Wu, Wei
    Gao, Yidan
    Xie, Minxiang
    Xia, Anqi
    He, Jiaying
    Zhang, Qianqian
    Han, Yuru
    Wang, Nan
    Zhu, Guangqi
    Wang, Qiujing
    Zhang, Zheen
    Mayer, Christian T.
    Wang, Kang
    Wang, Xiangxi
    Wang, Junqing
    Chen, Zhenguo
    Jiang, Shibo
    Sun, Lei
    Xia, Rong
    Wang, Qiao
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
  • [5] SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
    Hannes Lindahl
    Puran Chen
    Mikael Åberg
    Hans-Gustaf Ljunggren
    Marcus Buggert
    Soo Aleman
    C. I. Edvard Smith
    Peter Bergman
    Journal of Clinical Immunology, 2023, 43 : 1075 - 1082
  • [6] SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
    Lindahl, Hannes
    Chen, Puran
    Aberg, Mikael
    Ljunggren, Hans-Gustaf
    Buggert, Marcus
    Aleman, Soo
    Smith, C. I. Edvard
    Bergman, Peter
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1075 - 1082
  • [7] Neutralizing and enhancing antibodies against SARS-CoV-2
    Liu, Yafei
    Arase, Hisashi
    INFLAMMATION AND REGENERATION, 2022, 42 (01)
  • [8] Neutralizing and enhancing antibodies against SARS-CoV-2
    Yafei Liu
    Hisashi Arase
    Inflammation and Regeneration, 42
  • [9] Cross-reactive antibody immunity against SARS-CoV-2 in children and adults
    Elizabeth Fraley
    Cas LeMaster
    Dithi Banerjee
    Santosh Khanal
    Rangaraj Selvarangan
    Todd Bradley
    Cellular & Molecular Immunology, 2021, 18 : 1826 - 1828
  • [10] Cross-reactive antibody immunity against SARS-CoV-2 in children and adults
    Fraley, Elizabeth
    LeMaster, Cas
    Banerjee, Dithi
    Khanal, Santosh
    Selvarangan, Rangaraj
    Bradley, Todd
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (07) : 1826 - 1828